1. Morphological MRI investigations of the hypothalamus in 232 individuals with Parkinson's disease
- Author
-
Hans-Peter Müller, Daniel G. Schmidt, Jan Kassubek, Albert C. Ludolph, Martin Gorges, Barbara Kuntz, Kelly Del Tredici, Luc Dupuis, University of Ulm (UUlm), Mécanismes Centraux et Périphériques de la Neurodégénérescence, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Dieterle, Stéphane
- Subjects
Male ,0301 basic medicine ,Pathology ,Parkinson's disease ,Movement disorders ,[SDV]Life Sciences [q-bio] ,Volumetric analysis ,Disease ,MESH: Magnetic Resonance Imaging ,Cohort Studies ,MESH: Aged, 80 and over ,0302 clinical medicine ,hypothalamus ,MESH: Cohort Studies ,Aged, 80 and over ,MESH: Aged ,MESH: Middle Aged ,medicine.diagnostic_test ,Parkinson Disease ,Middle Aged ,Magnetic Resonance Imaging ,Pathophysiology ,3. Good health ,[SDV] Life Sciences [q-bio] ,Parkinson disease ,Neurology ,Hypothalamus ,Female ,medicine.symptom ,MR imaging ,Adult ,medicine.medical_specialty ,Parkinson's disease neuropathological stages ,MESH: Atrophy ,03 medical and health sciences ,Magnetic resonance imaging ,Parkinsonian Disorders ,In vivo ,medicine ,Humans ,Parkinson-Krankheit ,ddc:610 ,Aged ,volumetry ,MESH: Humans ,MESH: Parkinsonian Disorders ,business.industry ,Kernspintomografie ,MESH: Adult ,medicine.disease ,MESH: Hypothalamus ,MESH: Male ,Large cohort ,030104 developmental biology ,Neurology (clinical) ,Atrophy ,business ,MESH: Female ,MESH: Parkinson Disease ,030217 neurology & neurosurgery - Abstract
International audience; Background: The pathophysiology of the hypothalamic involvement in Parkinson's disease (PD) is not well understood. The objective of this study was the quantification of hypothalamic volumes in vivo in PD.Methods: High-resolution T1 -weighted magnetic resonance imaging (MRI) data from 232 individuals with PD and 130 healthy non-PD individuals were used for quantification of the hypothalamic volumes.Results: The hypothalamus in PD was not atrophied, as indicated by volumetric analyses in the prospectively collected subcohort (30 PD, V = 921 ± 78 mm3 vs 30 non-PD, V = 917 ± 67 mm3 ; P = 0.850) and validated in a large cohort (202 PD, V = 925 ± 88 mm3 vs 100 non-PD, V = 932 ± 114 mm3 ; P = 0.602).Conclusions: Hypothalamic involvement in PD as shown by a large body of histopathological evidence does not appear to be detectable by MRI-based volumetric quantification. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
- Published
- 2019